Skip to content
The Policy VaultThe Policy Vault

Vytorin 10/80 mgCareFirst (Caremark)

primary dysbetalipoproteinemia

Initial criteria

  • Patient has been taking the 10/80 mg strength of ezetimibe/simvastatin (Vytorin) OR the 80 mg strength of simvastatin (Zocor) chronically for 12 months or more

Approval duration

36 months